Nanostring announces availability of the geomx cancer transcriptome atlas through the technology access program for digital spatial profiling

Nanostring technologies, inc. announced the availability of its new geomx™ cancer transcriptome atlasthrough the technology access program (tap) for the geomx digital spatial profiler (dsp). this new high-plex rna expression profiling panel provides the most informed view of the cancer transcriptome based on evidence from the cancer genome atlas program as well as important immuno-oncology biology. the assay is compatible with both fresh frozen (ff) and formalin-fixed paraffin-embedded tissue (ffpe) enabling researchers to access more samples to power their studies. nanostring’s geomx dsp is used to prepare the sample for spatial analysis using a read-out chemistry designed to be compatible with illumina’s next-generation sequencing instruments.
NSTG Ratings Summary
NSTG Quant Ranking